129 related articles for article (PubMed ID: 14502094)
1. The galanin antagonist M35 has intrinsic agonistic activity in the dorsal root ganglion.
Mahoney SA; Hosking R; Wynick D
Neuroreport; 2003 Aug; 14(12):1649-52. PubMed ID: 14502094
[TBL] [Abstract][Full Text] [Related]
2. The second galanin receptor GalR2 plays a key role in neurite outgrowth from adult sensory neurons.
Mahoney SA; Hosking R; Farrant S; Holmes FE; Jacoby AS; Shine J; Iismaa TP; Scott MK; Schmidt R; Wynick D
J Neurosci; 2003 Jan; 23(2):416-21. PubMed ID: 12533601
[TBL] [Abstract][Full Text] [Related]
3. Binding and agonist/antagonist actions of M35, galanin(1-13)-bradykinin(2-9)amide chimeric peptide, in Rin m 5F insulinoma cells.
Kask K; Berthold M; Bourne J; Andell S; Langel U; Bartfai T
Regul Pept; 1995 Nov; 59(3):341-8. PubMed ID: 8577939
[TBL] [Abstract][Full Text] [Related]
4. Galanin receptor antagonist m35 but not m40 or c7 ameliorates cerulein-induced acute pancreatitis in mice.
Bhandari M; Kawamoto M; Thomas AC; Barreto SG; Schloithe AC; Carati CJ; Toouli J; Saccone GT
Pancreatology; 2010; 10(6):682-8. PubMed ID: 21242707
[TBL] [Abstract][Full Text] [Related]
5. Effects of putative galanin antagonists M35 and C7 on rat exocrine pancreas.
Kisfalvi I; Rácz G; Bálint A; Máté M; Oláh A; Zelles T; Vizi ES; Varga G
J Physiol Paris; 2001; 95(1-6):385-9. PubMed ID: 11595464
[TBL] [Abstract][Full Text] [Related]
6. Regulation of feeding by galnon.
Abramov U; Florén A; Echevarria DJ; Brewer A; Manuzon H; Robinson JK; Bartfai T; Vasar E; Langel U
Neuropeptides; 2004 Feb; 38(1):55-61. PubMed ID: 15003717
[TBL] [Abstract][Full Text] [Related]
7. Evidence for endogenous inhibition of autotomy by galanin in the rat after sciatic nerve section: demonstrated by chronic intrathecal infusion of a high affinity galanin receptor antagonist.
Verge VM; Xu XJ; Langel U; Hökfelt T; Wiesenfeld-Hallin Z; Bartfai T
Neurosci Lett; 1993 Jan; 149(2):193-7. PubMed ID: 7682681
[TBL] [Abstract][Full Text] [Related]
8. Enhanced hippocampal noradrenaline and serotonin release in galanin-overexpressing mice after repeated forced swimming test.
Yoshitake T; Wang FH; Kuteeva E; Holmberg K; Yamaguchi M; Crawley JN; Steiner R; Bartfai T; Ogren SO; Hökfelt T; Kehr J
Proc Natl Acad Sci U S A; 2004 Jan; 101(1):354-9. PubMed ID: 14701907
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory modulation of cutaneous vascular responses by endogenous galanin in the pigeon.
Sántha P; Pierau FK; Jancsó G
Neurosci Lett; 1999 Sep; 273(1):64-6. PubMed ID: 10505653
[TBL] [Abstract][Full Text] [Related]
10. Blockade of galanin-induced inhibition of insulin secretion from isolated mouse islets by the non-methionine containing antagonist M35.
Gregersen S; Lindskog S; Land T; Langel U; Bartfai T; Ahrén B
Eur J Pharmacol; 1993 Feb; 232(1):35-9. PubMed ID: 7681407
[TBL] [Abstract][Full Text] [Related]
11. Differential effects of the putative galanin receptor antagonists M15 and M35 on striatal acetylcholine release.
Ogren SO; Pramanik A; Land T; Langel U
Eur J Pharmacol; 1993 Sep; 242(1):59-64. PubMed ID: 7693496
[TBL] [Abstract][Full Text] [Related]
12. On the role of galanin in mediating spinal flexor reflex excitability in inflammation.
Xu IS; Grass S; Xu XJ; Wiesenfeld-Hallin Z
Neuroscience; 1998 Aug; 85(3):827-35. PubMed ID: 9639276
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory neurogenic modulation of histamine-induced cutaneous plasma extravasation in the pigeon.
Jancsó G; Sántha P; Horváth V; Pierau F
Regul Pept; 2000 Nov; 95(1-3):75-80. PubMed ID: 11062335
[TBL] [Abstract][Full Text] [Related]
14. Evidence for a role of the neuropeptide galanin in spatial learning.
Ogren SO; Hökfelt T; Kask K; Langel U; Bartfai T
Neuroscience; 1992 Nov; 51(1):1-5. PubMed ID: 1281521
[TBL] [Abstract][Full Text] [Related]
15. Effect of M35, a neuropeptide galanin antagonist on glucose uptake translated by glucose transporter 4 in trained rat skeletal muscle.
Jiang L; Shi M; Guo L; He B; Li G; Zhang L; Zhang L; Shao H
Neurosci Lett; 2009 Dec; 467(2):178-81. PubMed ID: 19835935
[TBL] [Abstract][Full Text] [Related]
16. Galanin receptor antagonists : a potential novel pharmacological treatment for mood disorders.
Ogren SO; Kuteeva E; Hökfelt T; Kehr J
CNS Drugs; 2006; 20(8):633-54. PubMed ID: 16863269
[TBL] [Abstract][Full Text] [Related]
17. Galanin-mediated control of pain: enhanced role after nerve injury.
Wiesenfeld-Hallin Z; Xu XJ; Langel U; Bedecs K; Hökfelt T; Bartfai T
Proc Natl Acad Sci U S A; 1992 Apr; 89(8):3334-7. PubMed ID: 1373497
[TBL] [Abstract][Full Text] [Related]
18. Galanin-(1-16) modulates 5-HT1A receptors in the ventral limbic cortex of the rat.
Díaz-Cabiale Z; Narváez JA; Finnman UB; Bellido I; Ogren SO; Fuxe K
Neuroreport; 2000 Feb; 11(3):515-9. PubMed ID: 10718306
[TBL] [Abstract][Full Text] [Related]
19. Galanin-neuropeptide Y (NPY) interactions in central cardiovascular control: involvement of the NPY Y receptor subtype.
Díaz-Cabiale Z; Parrado C; Rivera A; de la Calle A; Agnati L; Fuxe K; Narváez JA
Eur J Neurosci; 2006 Jul; 24(2):499-508. PubMed ID: 16903855
[TBL] [Abstract][Full Text] [Related]
20. Differential effect of galanin on proliferation of PC12 and B104 cells.
Cheng S; Yuan CG
Neuroreport; 2007 Aug; 18(13):1379-83. PubMed ID: 17762717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
